ImmunityBio, Inc 10-Q for FY2023 Q3
ImmunityBio, Inc. (IBRX)
10-Q
2023-11-09
For: 2023-09-30
View Original
Added on
April 10, 2026
About this 10-Q
ImmunityBio, Inc filed this 10-Q on November 9, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).
Headline figures
Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $82K
- down 30.5% from $118K a year earlier
- Net loss
- $95.58M
- compared with a net loss of $110.94M a year earlier
- Diluted EPS
- -$0.19
- compared with -$0.28 a year earlier